Text Size

Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2004 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173030
First received: September 12, 2005
Last updated: NA
Last verified: April 2004
History: No changes posted
  Purpose

Multi-locus and multi-gene studies of atrial fibrillation, focusing on renin-angiotensin system genes and C reactive protein gene


Condition
Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Time Perspective: Prospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

  Eligibility

Ages Eligible for Study:   20 Years to 90 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patients with atrial fibrillation

Exclusion Criteria:

  • Patients with atrial fibrillation who are reluctant for the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00173030

Contacts
Contact: Chia-Ti Tsai, MD 886-2-23123456 ext 5761 fang31@ms39.hinet.net

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan
Contact: Chia-Ti Tsai            
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Chair: Jiunn-Lee Lin National Taiwan University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00173030     History of Changes
Other Study ID Numbers: 9361700499
Study First Received: September 12, 2005
Last Updated: September 12, 2005
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 16, 2013